Abstract
Even before the European Patent Convention came into force, there were proposals for a Community Patent. However, the political will has not been there to implement this. Recently, with the EU falling behind the US in innovation, and this being blamed on the high cost of obtaining comprehensive patent cover in the EU, the Community Patent has surfaced to near the top of the political agenda. While business wants the Community Patent, several Member States are finding it difficult to give up on language and local jurisdiction. The Community Patent is wanted by the pharmaceutical industry, for both research-based and generic categories, for different reasons. However, ‘Big Pharma’ will probably not want it to supplant a local patent system, although it might in time supplant the European bundle of patents. Much of the analysis concerning the Community Patent is general, but there are some issues which are of special concern to the pharmaceutical industry, particularly in the infringement area and in the area of cross-licensing. These include whether to obtain a Community Patent or to continue with the existing European or national patents.
Similar content being viewed by others
References
Commission proposes the creation of a Community Patent, EU Commission Press Release IP/00/714, 2000 Jul 5
Report from the Commission to the European Parliament and the Council, Brussels, 2000 Oct 27. COM (2002) 545 Final. Development and Implications of Patent Law in the Field of Biotechnology and Genetic Engineering
Conference on the Revision of the Convention on the Grant of European Patents (the European Patent Convention [EPC]). 2000 Nov 22–23; Munich.
Proposal for a Council Regulation on the Community Patent. Commission of the European Communities. COM (2000) 412 Final, 2000 Aug 1
Council Regulation (EEC) 1768/92 concerning the creation of a supplementary protection certificate for medicinal products, 1992 Jun 18
The Lord Chancellor’s Department Civil Justice Reform Evaluation (2000) [online]. Available from URL: http://www.lcd.gov.uk/civil/reform/ffreform [Accessed 2003 Apr 1]
Reference Official Journal (OJ) of the European Communities, Section C27, 1998 Jan 26
Convention on jurisdiction and judgements in civil and commercial matters, Article 2. Brussels, 1968 Sep 27
Convention on jurisdiction and judgements in civil and commercial matters, Article 5(3), Brussels. (Handelskwekerij G.J. Bier v. Mines des Potasse D’Alsace 21/76 [1976] ECJ 1284)
Council Regulation 44/2001/EC, Article 6(2). Jurisdiction and the recognition and enforcement of judgements in civil and commercial matters, 2000 Dec 22
Council Regulation 44/2001/EC, Article 22(4). Jurisdiction and the recognition and enforcement of judgements in civil and commerical matters, 2000 Dec 22
Council Regulation 44/2001/EC. Jurisdiction and the recognition and enforcement of judgements in civil and commercial matters, 2000 Dec 22
Convention on the Grant of European Patents (EPC), Articles 52–57. Munich, Germany, 1973 Oct 5
Convention on the Grant of European Patents (EPC), Article 116. Munich, Germany, 1973 Oct 5
Convention on the Grant of European Patents (EPC), Article 105. Munich, Germany, 1973 Oct 5
Buehler v Chronos [1998] RPC 609
Patents Act 1977, sections 48A(1)(a) and (b), based on the WTO Trips Articles 8.2, 30 and 31
Proposal for a Council Regulation on the Community Patent. Commission of the European Communities. COM (2000) 412 Final, 2000 Aug 1
The latest proposals from the EU Commission are contained in the Commission Working Document on the Planned Community Patent Jurisdiction, 2002 Aug 30, COM (2002) 480 Final
Working document, Articles 4 and 13 and commentary
Working document, Article 5 and commentary
Working document, Article 25 and commentary
Proposed Article 13 of the Community Patent Regulation
EC Regulation 83/2001/EC, Article 10.1(a)(iii)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cohen, L.J. The Community Patent. Pharm Dev Regul 1, 3–10 (2003). https://doi.org/10.1007/BF03257361
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257361